Colorectal cancer is the third most common cancer in Indonesia with approximately 28,000 patients diagnosed each year. Without population-based screening, patients are often treated when they reach the advanced stage. Bevacizumab, a newly available high-cost treatment for metastatic colorectal ca

As countries develop their health systems on the path to Universal Health Coverage (UHC) (#LeaveNoOneBehind), many countries are experimenting with the development of a health technology assessment (HTA) agency in order to set priorities for health benefit packages, make go/no go decisions about

Kidney failure (KF)[1] is a life-threatening disease that requires either kidney transplantation or dialysis for survival (1, 2). As of 2019, it was estimated that globally, 1.4 million deaths occurred on account of chronic kidney disease (CKD) (3). The cost of treatment for KF is also high, leading to catastrophic household expenditure to househo

Tuberculosis (TB) is an infectious disease caused by Mycobacterium tuberculosis (MTB) and represents a significant global health concern. Infectious agents can be easily spread through respiratory droplets, and TB patients face a significant risk of mortality. The traditional sputum-based TB

Cervical cancer is a global public health problem, with approximately 500,000 new cases are identified each year globally. The disease is the most common cancer in women in the developing world and its mortality is very high–nearly 300,000 per year, 80% of which are in resource-poor settings. Human papillomavirus (HPV) has been proven as a major

This policy brief provides a summary of a recent review of the definition of rare diseases, high cost and how HTA has been used in the case of rare diseases in seven countries. The countries were purposively selected based on them having established HTA policies and availability of resources in the

MEAs aim at early access to high-cost innovative medicines at pre-determined terms that can ensure the financial sustainability of healthcare systems. However, their successful adoption hinges on a consideration of various factors to address the unique challenges faced by different nations. The a

Familial Hypercholesterolemia (FH) is a genetic disorder characterized by elevated cholesterol levels, significantly increasing the risk of heart disease. Early detection through genetic screening can play a crucial role in preventing serious health outcomes. This study marks the first global eco

201-369-2555HITA,HITAP,HTA,method guidelines,การประเมินความคุ้มค่าด้านสุขภาพ

COVID-19 has shown that irresepctive of national borders, the infectious disease brings multi-dimensional challenges requiring concerted global and regional efforts to address it. In contrast to the European Union and the African Union, the Association of Southeast Asian Nations (ASEAN), the regional cooperation body in Southeast Asia, has had no e